Fight against patent for hepatitis C drug that can cost €55,000

Sofosbuvir can cost up to €55,000 for a course of treatment. Charities hope revoking the patent would allow far cheaper generics to cure hepatitis C in Europe

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nMq0m3
via IFTTT